Comorbidity, age and overall survival in patients with advanced pancreatic cancer – Results from NCIC CTG PA.3: A phase III trial of gemcitabine plus erlotinib or placebo

✍ Scribed by M.M. Vickers; E.D. Powell; T.R. Asmis; D.J. Jonker; J.F. Hilton; C.J. O’Callaghan; D. Tu; W. Parulekar; M.J. Moore

• Book ID: 116430927
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 305 KB
• Volume: 48
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2011.10.035